Author:
Pinton Giulia,Nilsson Stefan,Moro Laura
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology
Reference35 articles.
1. Halon, A. et al. Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients. Anticancer Res. 31, 711–718 (2011).
2. Kemp, Z. & Ledermann, J. Update on first-line treatment of advanced ovarian carcinoma. Int. J. Womens Health 5, 45–51 (2013).
3. Köbel, M. et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 5, e232 (2008).
4. Lalwani, N. et al. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31, 625–646 (2011).
5. Beral, V., Million Women Study Collaborators, Bull, D., Green, J. & Reeves, G. Ovarian cancer and hormone replacement therapy in the Million Women study. Lancet 369, 1703–1710 (2007).
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献